awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33414307-9C53A423-AF52-4816-B95F-6812635DDCAF
Q33414307-9C53A423-AF52-4816-B95F-6812635DDCAF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414307-9C53A423-AF52-4816-B95F-6812635DDCAF
A phase I/II study of the pan Bcl-2 inhibitor obatoclax mesylate plus bortezomib for relapsed or refractory mantle cell lymphoma.
P2093
Q33414307-9C53A423-AF52-4816-B95F-6812635DDCAF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414307-9C53A423-AF52-4816-B95F-6812635DDCAF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1d622312259fc354bef7b632e1650cd9e544b0ad
P1545
4
http://www.w3.org/2001/XMLSchema#string
P2093
Peggy Ford
http://www.w3.org/2001/XMLSchema#string